[Research and advertisement. Differences in the effectiveness of alendronate according to risk groups]
Aten Primaria
.
2001 Apr 30;27(7):528-30.
doi: 10.1016/s0212-6567(01)78852-x.
[Article in Spanish]
Authors
S Peiró
,
V Ortún Rubio
,
R Meneu
,
A García-Altés
,
M Ridao
,
E Bernal Delgado
PMID:
11334607
PMCID:
PMC7684096
DOI:
10.1016/s0212-6567(01)78852-x
No abstract available
Publication types
Letter
Comment
MeSH terms
Advertising*
Alendronate / therapeutic use*
Conflict of Interest
Drug Industry
Female
Fractures, Bone / prevention & control*
Humans
Research
Research Support as Topic
Risk
Substances
Alendronate